480 ARSENAL WAY, WATERTOWN, MA
Prefunded Warrant Exercise - Eloxx Pharmaceuticals Issues 2.5M Shares
Stockholder Actions: Approval of First Amendment to 2018 Equity Incentive Plan
News
News, Material Contracts
Material disclosure
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Entry into a Material Definitive Agreement
Q1
FY 2025
Notice of Late Filing for Quarterly Report
Notice of Late Filing for Annual Report
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Certificate
Amended Registration Statement for Securities
Registration of Securities
S-1
Registration Statement for Securities Offered under a Shelf Registration
Definitive Information Statement
Preliminary Information Statement
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
SEC Staff Action Letter
Confidential Treatment Order
Correspondence
Submission Upload